Business Context and Reporting Period
This Form 6-K filing is submitted by Hexindai Inc., a foreign private issuer, for the month of March 2018. The registrant's principal executive office is located in Beijing, People's Republic of China. The document serves as a report pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 and includes a press release as Exhibit 99.1.
Key Financial Metrics
The filing text provided does not contain specific financial data. There are no disclosed values for revenue, profit, cash flow, margins, debt, or liquidity within this document.
Material Changes
The filing text does not provide information regarding material changes versus the prior comparable period.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, risks, contingencies, or details on unusual items. The document primarily consists of the cover page, signature block, and an exhibit index.
Investor Verification Checklist
- Verify the content of the attached Press Release (Exhibit 99.1) for specific operational or financial updates.
- Confirm the discrepancy between the requested company name "Akso Health Group" and the registrant name "Hexindai Inc." listed in the filing.
- Review the full Form 20-F annual report for comprehensive financial statements, as this Form 6-K contains no numerical data.